Stock 300149 CHEMPARTNER PHARMATECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chempartner Pharmatech Co., Ltd.

Equities

300149

CNE100000Y27

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
4.42 CNY -5.35% Intraday chart for Chempartner Pharmatech Co., Ltd. -8.30% -42.22%
Jan. 10 Chempartner Pharmatech Announces Resolutions of the The First Extraordinary General Meeting of Shareholders 2024. CI
2023 MEGA STAR CENTRE LIMITED Announces Nominee to the Board of Chempartner Pharmatech. CI

Business Summary

ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.

Number of employees: 2,072

Sales per Business

CNY in Million2021Weight2022Weight Delta
Pharmaceutical Research and Development and Production Outsourcing
89.8 %
1,358 80.3 % 1,191 89.8 % -12.30%
Microecological Nutrition and Medical
10.3 %
333 19.7 % 137 10.3 % -58.87%
Inter-segment Elimination
-0.5 %
-23 -1.4 % -6 -0.5 % -73.75%
Headquarters and Industry
0.3 %
22 1.3 % 4 0.3 % -80.80%

Sales per region

CNY in Million2021Weight2022Weight Delta
United States
59.2 %
825 48.8 % 785 59.2 % -4.79%
China
29.5 %
663 39.2 % 392 29.5 % -40.87%
Other Countries or Regions
11.3 %
203 12.0 % 149 11.3 % -26.41%

Managers

Managers TitleAgeSince
Ji Guo Zhang CEO
 Chief Executive Officer 51 23-02-07
Yin Qun Cha DFI
 Director of Finance/CFO 45 23-10-07
Hong Hui Li IRC
 Investor Relations Contact - -
Jian Xu SEC
 Corporate Secretary 40 22-03-07
Wang Long Chen PRN
 Corporate Officer/Principal 52 21-07-31

Members of the board

Members of the board TitleAgeSince
Xin Hui BRD
 Director/Board Member 53 18-07-31
Chi Shing Kwok BRD
 Director/Board Member 62 20-10-11
Xian Zhong Wang BRD
 Director/Board Member 54 21-08-22
Jia Hui Qi BRD
 Director/Board Member 51 18-06-30
Ji Guo Zhang CEO
 Chief Executive Officer 51 23-02-07
Da Chao Zhang CHM
 Chairman 50 21-08-23
Wang Long Chen PRN
 Corporate Officer/Principal 52 21-07-31
Shi Xin Fan BRD
 Director/Board Member 59 21-11-16
Ling Yang BRD
 Director/Board Member 63 23-08-29
Wen Ya Wang BRD
 Director/Board Member 41 23-03-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 499,776,892 115,722,016 ( 23.15 %) 1,812,900 ( 0.3627 %) 23.15 %

Shareholders

NameEquities%Valuation
Zeng Xian Jing Family
13.72 %
68,441,800 13.72 % 52 M ¥
Shanghai Ruiyun Enterprise Management Center LP
6.891 %
34,380,629 6.891 % 26 M ¥
Rongtong Fund Management Co., Ltd.
4.269 %
21,299,950 4.269 % 16 M ¥
Xian Jing Zeng
2.557 %
12,755,275 2.557 % 10 M ¥
Beixin Ruifeng Fund Management Co., Ltd.
0.0932 %
465,000 0.0932 % 355 144 ¥
Gfund Management Co., Ltd.
0.0598 %
298,266 0.0598 % 227 801 ¥
Hwabao WP Fund Management Co., Ltd.
0.0591 %
295,000 0.0591 % 225 306 ¥
Wanjia Asset Management Co., Ltd.
0.0535 %
266,800 0.0535 % 203 769 ¥
Tian Hong Asset Management Co., Ltd.
0.0190 %
94,900 0.0190 % 72 480 ¥
GF Fund Management Co., Ltd.
0.004530 %
22,600 0.004530 % 17 261 ¥

Company contact information

ChemPartner PharmaTech Co., Ltd.

28 F, Exchange Plaza 268 Dongfeng Middle Road

510031, Guangzhou

+

http://www.cppt.com.cn
address Chempartner Pharmatech Co., Ltd.(300149)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CHEMPARTNER PHARMATECH CO., LTD. Stock Chempartner Pharmatech Co., Ltd.
-42.22% 304M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.02% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+46.17% 40.08B
MODERNA, INC. Stock Moderna, Inc.
+5.04% 40B
CELLTRION, INC. Stock Celltrion, Inc.
-11.32% 26.87B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.25% 24.58B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.83% 18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.62% 11.94B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+22.75% 11.66B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.44% 11.01B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 300149 Stock
  4. Company Chempartner Pharmatech Co., Ltd.